Polymorphic patterns of pfcrt and pfmdr1 in Plasmodium falciparum isolates along the Thai-Myanmar border

Asian Pacific Journal of Tropical Biomedicine

Volumn 3, Issue 12, 2013, Pages 931-935

  Muhamad, Phunuch ^a   Chaijaroenkul, Wanna ^a   Phompradit, Papichaya ^a   Rueangweerayut, Ronnatrai ^b   Tippawangkosol, Pongsri ^c   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAE SOT GENERAL HOSPITAL   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Gene copy number; Gene mutation; Multidrug resistance; Pfcrt; Pfmdr1; Plasmodium falciparum

Indexed keywords

ARTESUNATE; CARRIER PROTEIN; CHLOROQUINE; CHLOROQUINE RESISTANCE TRANSPORTER; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN 1; PROTOZOAL DNA; UNCLASSIFIED DRUG;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; GENE DOSAGE; GENE MUTATION; GENETIC POLYMORPHISM; MYANMAR; NONHUMAN; PARASITE ISOLATION; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THAILAND; WILD TYPE;

GENE COPY NUMBER; GENE MUTATION; MULTIDRUG RESISTANCE; PFCRT; PFMDR1; PLASMODIUM FALCIPARUM;

BLOOD; CODON; DNA, PROTOZOAN; GENE DOSAGE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS; THAILAND;

EID: 84884736649     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(13)60181-1     Document Type: Article

References (30)

1. Aungkulanon S, McCarron M, Lertiendumrong J, Olsen S, Bundhamcharoen K Infectious disease mortality rates, Thailand, 1958-2009. Emerg Infect Dis 2012, 18(11):1794-1801.
2. Na-Bangchang K, Congpuong K Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. Tohoku J Exp Med 2007, 211(2):99-113.
3. Kaewpitoon S, Rujiragul R, Namwichaisirikul N, Churproong S, Ueng-arporn N, Matrakool L, et al. Malaria in Thailand 2007-2011. Srinagarind Med J 2012, 27(Suppl):118-120.
4. Na-Bangchang K, Karbwang J Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Fundam Clin Pharmacol 2009, 23:387-409.
5. Marfurt J, Müller I, Sie A, Oa O, Reeder J, Smith T, et al. The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea. Malar J 2008, 7:61.
6. Sanchez C, Dave A, Stein W, Lanzer M Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol 2010, 40(10):1109-1118.
7. Mungthin M, Suwandittakul N, Chaijaroenkul W, Rungsrihirunrat K, Harnyuttanakorn P, Seugorn A, et al. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003. Parasitol Res 2010, 107(3):539-545.
8. Eyase F, Akala H, Ingasia L, Cheruiyot A, Omondi A, Okudo C, et al. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011. PLoS One 2013, 8(5):64299.
9. Lim P, Alker A, Khim N, Shah N, Incardona S, Doung S, et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J 2009, 8:11-17.
10. Witkowski B, Iriart X, Soh P, Menard S, Alvarez M, Naneix-Laroche V, et al. Pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies. J Clin Microbiol 2010, 48(10):3797-3799.
11. Wooden J, Gould E, Paull A, Sibley C Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Exp Parasitol 1992, 75(2):207-212.
12. Fidock D, Nomura T, Talley A, Cooper R, Dzekunov S, Ferdig M, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol Cell 2000, 6(4):861-871.
13. Djimdé A, Doumbo O, Cortese J, Kayentao K, Doumbo S, Diourté Y, et al. A molecular marker for chloroquine resistant falciparum malaria. N Engl J Med 2001, 334(4):257-263.
14. Ferreira I, Rosario V, Cravo P Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar J 2006, 5:1.
15. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Acta Trop 2010, 113(2):190-194.
16. Mehlotra R, Mattera G, Bockarie M, Maguire J, Baird J, Sharma Y, et al. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 2008, 52(6):2212-2222.
17. Vinayak S, Alam M, Sem R, Shah N, Susanti A, Lim P, et al. Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia. J Infect Dis 2010, 201(10):1551-1560.
18. Huang F, Tang L, Yang H, Zhou S, Liu H, Li J, et al. Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China. Malar J 2012, 11:243.
19. Brown T, Smith L, Oo E, Shawng K, Lee T, Sullivan D, et al. Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies. Malar J 2012, 19:333.
20. Barber B, William T, Grigg M, Yeo T, Anstey N Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi. Malar J 2013, 12:8.
21. Lekana-Douki J, Dinzouna Boutamba S, Zatra R, Zang Edou S, Ekomy H, Bisvigou U, et al. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Infect Genet Evol 2011, 11(2):512-517.
22. Wongsrichanalai C, Meshnick S Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis 2008, 14(5):716-719.
23. Congpuong K, Na Bangchang K, Mungthin M, Bualombai P, Wernsdorfer W Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand. Trop Med Int Health 2005, 10(8):717-722.
24. Zatra R, Lekana-douki J, Lekoulou F, Bisvigou U, Ngoungou E, Ndouo F In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon. BMC Infect Dis 2012, 12:307.
25. Muhamad P, Phompradit P, Sornjai W, Maensathian T, Chaijaroenkul W, Rueangweerayut R, et al. Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 2011, 85(3):568-572.
26. Phompradit P, Wisedpanichkij R, Muhamad P, Chaijaroenkul W, Na-Bangchang K Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Acta Trop 2011, 120(1-2):130-135.
27. Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008, 359(24):2619-2620.
28. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis 2010, 51(11):82-89.
29. Noedl H, Socheat D, Satimai W Artemisinin-resistant malaria in Asia. N Engl J Med 2009, 361(5):540-541.
30. Satimai W, Sudathip P, Vijaykadga S, Khamsiriwatchara A, Sawang S, Potithavoranan T, et al. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Malar J 2012, 11:300.